Author:
Leeman Jan,Dendale Paul,Franken Philippe,De Wilde Philippe,Block Pierre
Subject
Cardiology and Cardiovascular Medicine
Reference12 articles.
1. Perper EJ, Segall GM (1991) Safety of dipyridamole-thallium imaging in high risk patients with known or suspected coronary artery disease. J Nucl Med 32:2107–2114.
2. Homma S, Callahan RJ, Ameer B, et al. (1992) Usefulness of oral dipyridamole suspension for stress thallium imaging without exercise in the detection of coronary artery disease. Am J Cardiol 57:503–508.
3. Pfisterer M (1992) Intravenous dipyridamole for stress thallium-201 myocardial perfusion scintigraphy. Cardiovasc Imag 4:31–34.
4. Jain A, Mahmarian JJ, Borges-Neto S, et al. (1988) Clinical significance of perfusion defects by thallium-201 single photon emission tomography following oral dipyridamole early after coronary angioplasty. J Am Coll Cardiol 11:970–976.
5. Borges-Neto S, Mahmarian JJ, Jain A, et al. (1988) Quantitative thallium-201 single photon emission computed tomography after oral dipyridamole for assessing the presence, anatomic location and severity of coronary artery disease. J Am Coll Cardiol 11: 962–969.